A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study is a single-arm, single-center, open-label, multiple-dose, dose-escalation early clinical study aimed at evaluating the safety, tolerability, and pharmacokinetic profile of STR-P004 in subjects with relapsed/refractory CD19-positive B-cell non-Hodgkin lymphoma, and preliminarily observing its antitumor activity.
Epistemonikos ID: 6c29897727173c4777c631310f46bff0185448c7
First added on: Apr 17, 2026